MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer

Cellular Physiology and Biochemistry

Volumn 35, Issue 5, 2015, Pages 2033-2042

  Li, Xiaoping ^a   Li, Hong ^b   Zhang, Rui ^c   Liu, Jing ^c   Liu, Jun ^c  

^a NANTONG UNIVERSITY   (China)

^b SHAANXI UNIVERSITY OF CHINESE MEDICINE   (China)

^c TAIXING PEOPLE'S HOSPITAL   (China)

Author keywords

Apoptosis; E2F3; Gastric cancer; MiR 449a; Proliferation

Indexed keywords

CISPLATIN; MICRORNA; MICRORNA 449A; TRANSCRIPTION FACTOR E2F3; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; E2F3 PROTEIN, HUMAN; MIRN449 MICRORNA, HUMAN; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CLONOGENESIS; COLONY FORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; UPREGULATION; WESTERN BLOTTING; 3' UNTRANSLATED REGION; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA INTERFERENCE; SEQUENCE ALIGNMENT; STOMACH TUMOR;

3' UNTRANSLATED REGIONS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CELL PROLIFERATION; CISPLATIN; DOWN-REGULATION; E2F3 TRANSCRIPTION FACTOR; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ALIGNMENT; STOMACH NEOPLASMS;

EID: 84927931838     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374010     Document Type: Article

References (32)

1. Herszenyi L, Tulassay Z: Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 2010;14:249-258.
2. Kim SJ, Wang YG, Lee HW, Kang HG, La SH, Choi IJ, Irimura T, Ro JY, Bresalier RS, Chun KH: Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer. Oncotarget 2014;5:3386-3398.
3. Ren J, Huang HJ, Gong Y, Yue S, Tang LM, Cheng SY: MicroRNA-206 suppresses gastric cancer cell growth and metastasis. Cell Biosci 2014;4:26.
4. Li Q, Wang JX, He YQ, Feng C, Zhang XJ, Sheng JQ, Li PF: MicroRNA-185 regulates chemotherapeutic sensitivity in gastric cancer by targeting apoptosis repressor with caspase recruitment domain. Cell Death Dis 2014;5:e1197.
5. Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-866.
6. Ishiguro H, Kimura M, Takeyama H: Role of microRNAs in gastric cancer. World J Gastroenterol 2014;20:5694-5699.
7. Chen H, Lin YW, Mao YQ, Wu J, Liu YF, Zheng XY, Xie LP: MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins. Cancer Lett 2012;320:40-47.
8. Smoot DT, Sewchand J, Young K, Desbordes BC, Allen CR, Naab T: A method for establishing primary cultures of human gastric epithelial cells. Methods Cell Sci 2000;22:133-136.
9. Chen P, Huang Y, Zhang B, Wang Q, Bai P: EphA2 enhances the proliferation and invasion ability of LNCaP prostate cancer cells. Oncol Lett 2014;8:41-46.
10. Madhavan J, Mitra M, Mallikarjuna K, Pranav O, Srinivasan R, Nagpal A, Venkatesan P, Kumaramanickavel G: KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association. Mol Vis 2009;15:235-240.
11. Liu T, Hou L, Huang Y: EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway. Tumour Biol 2014;35:7239-7247.
12. Iyer G, Milowsky MI: Fibroblast growth factor receptor-3 in urothelial tumorigenesis. Urol Oncol 2013;31:303-311.
13. Tian L, Li M, Ge J, Guo Y, Sun Y, Liu M, Xiao H: MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours. Tumour Biol 2014;35:5953-5963.
14. Ye W, Xue J, Zhang Q, Li F, Zhang W, Chen H, Huang Y, Zheng F: MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A. Oncol Rep 2014;32:1193-1199.
15. Ren XS, Yin MH, Zhang X, Wang Z, Feng SP, Wang GX, Luo YJ, Liang PZ, Yang XQ, He JX, Zhang BL: Tumorsuppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells. Cancer Lett 2014;344:195-203.
16. Hu J, Fang Y, Cao Y, Qin R, Chen Q: miR-449a regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells. Dig Dis Sci 2014;59:336-345.
17. Lize M, Klimke A, Dobbelstein M: MicroRNA-449 in cell fate determination. Cell Cycle 2011;10:2874-2882.
18. Lize M, Pilarski S, Dobbelstein M: E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis. Cell Death Differ 2010;17:452-458.
19. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR: MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838.
20. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103:2257-2261.
21. Jeon HS, Lee SY, Lee EJ, Yun SC, Cha EJ, Choi E, Na MJ, Park JY, Kang J, Son JW: Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer. Lung Cancer 2012;76:171-176.
22. Buurman R, Gurlevik E, Schaffer V, Eilers M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kuhnel F, Skawran B: Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Gastroenterology 2012;143:811-820 e811-815.
23. Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, Krogh A, Bardram L, Hother C, Gronbaek K, Federspiel B, Lund AH, Friis-Hansen L: miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer 2011;10:29.
24. Yang X, Feng M, Jiang X, Wu Z, Li Z, Aau M, Yu Q: miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A. Genes Dev 2009;23:2388-2393.
25. Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, Hirata H, Giardina C, Dahiya R: miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 2009;28:1714-1724.
26. Noonan EJ, Place RF, Basak S, Pookot D, Li LC: miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 2010;1:349-358.
27. Zhang Q, He XJ, Ma LP, Li N, Yang J, Cheng YX, Cui H: [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues]. Zhonghua Zhong Liu Za Zhi 2011;33:885-890.
28. Chen HZ, Tsai SY, Leone G: Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 2009;9:785-797.
29. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML, Leone G: The E2F1-3 transcription factors are essential for cellular proliferation. Nature 2001;414:457-462.
30. Sharma N, Timmers C, Trikha P, Saavedra HI, Obery A, Leone G: Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformation. J Biol Chem 2006;281:36124-36131.
31. He L, Yang H, Ma Y, Pledger WJ, Cress WD, Cheng JQ: Identification of Aurora-A as a direct target of E2F3 during G2/M cell cycle progression. J Biol Chem 2008;283:31012-31020.
32. Jiang Y, Saavedra HI, Holloway MP, Leone G, Altura RA: Aberrant regulation of survivin by the RB/E2F family of proteins. J Biol Chem 2004;279:40511-40520.